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	‘Genetic	Resources’,	an	analysis	of	a	multifaceted	concept		
Abstract		
‘Genetic	resources’	is	a	key	concept	of	the	Convention	on	Biological	Diversity	
(CBD)	and	the	Nagoya	Protocol	(NP).	However,	the	term	was	coined	to	describe	
value	in	biodiversity	and	create	an	incentive	for	its	protection	and	is	thus	of	
practical	relevance	for	biological	conservation	beyond	the	legal	context.	The	
scope	of	this	concept	is	also	of	interest	to	researchers,	who	may	be	unsure	for	
which	types	of	analysis	they	are	legally	and	ethically	expected	to	enter	access	and	
benefit	sharing	(ABS)	negotiations.	This	article	presents	a	biologically	informed	
analysis,	which	leads	to	an	understanding	of	‘genetic	resources’	that	considers	
various	associations	and	implications	of	this	notion,	such	as	its	relation	to	
biodiversity	and	the	role	that	intellectual	property	rights	(IPR)	play	in	the	
discourse.	The	aim	is	to	provide	a	coherent,	consistent	and	comprehensive	
understanding	of	the	concept	that	can	integrate	and	explain	these	aspects	and	
consider	both	classical	and	novel	ways	of	using	genetic	resources.	Based	on	the	
biological	function	of	genetic	resources	and	an	analysis	of	how	they	are	currently	
used	and	valued,	this	article	argues	that	genetic	resources	are	a	particular	type	of	
natural	resource	that	is	informational	rather	than	tangible.	This	interpretation	
clearly	identifies	utilising	digital	genomic	sequences	as	a	form	of	using	genetic	
resources.	However,	the	article	also	discusses	regulatory	exceptions	for	certain	
utilisations	of	genetic	resources	and	it	mentions	the	possibility	of	treating	digital	
sequences	as	such	an	exception.	
	
Keywords:	biodiversity,	Convention	on	Biological	Diversity,	definition	of	genetic	resources,	intellectual	property,	Nagoya	Protocol,	natural	resources	
	
Highlights		- ‘Genetic	resources’	is	a	multifaceted	concept	with	interdisciplinary	connotations.	- The	term	‘genetic	resources’	refers	to	instrumental	value	in	biodiversity.	- In	many	respects,	genetic	resources	are	different	from	other	natural	resources.	- Their	biological	foundation	reveals	the	informational	nature	of	genetic	resources.	- The	resource	value	of	genetic	resources	lies	in	the	information	they	carry.	
	
1.	Introduction	The	term	‘genetic	resources’	has	received	wide	attention	as	a	key	concept	in	the	UN	Convention	on	Biological	Diversity	(CBD)	and	is	used	in	the	domestic	legislation	of	the	states	that	are	parties	to	the	CBD.	In	environmental	politics	and	communication,	the	term	is	used	to	emphasise	the	instrumental	value	of	biodiversity	and	to	explain	why	we	benefit	from	its	protection	and	conservation.1	Moreover,	ethicists	refer	to	genetic																																																									1E.g.:	WWF	“Arguments	for	protection”	http://wwf.panda.org/what_we_do/how_we_work/protected_areas/arguments_for_protection/	(accessed	December	2017)		
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resources,	for	instance,	in	their	discussion	of	fair	access	and	just	distribution	(e.g.,	De	Jonge,	2011;	Deplazes-Zemp,	2018;	Schroeder	&	Pogge,	2009).	The	concept	also	raises	various	legal,	policy	and	economic	questions,	for	instance,	concerning	the	implementation	of	an	access	and	benefit	sharing	(ABS)	scheme	for	genetic	resources	or	appropriate	property	regimes	(e.g.,	Kamau	Evanson	&	Winter,	2009;	Oberthür	&	Rosendal,	2013;	Ruiz	Muller,	2015;	Vogel,	1994).	Finally,	it	is	argued	here	that	because	the	term	’genetic	resources’	refers	to	usable,	useful	and	beneficiary	aspects	of	living	nature	(the	object	of	biology)	it	is	important	to	take	into	account	biological	features	and	characteristics	of	these	resources.	This	article	reflects	theoretically	on	the	concept	of	‘genetic	resources’,	with	the	aim	of	considering	and	combining	its	various	interdisciplinary	connotations.	It	is	not	a	legal	analysis	that	seeks	to	interpret	and	explain	the	concept	with	reference	to	other	legal	documents	and	decisions.	Instead,	it	is	an	argumentative	text	that	discusses	and	critically	examines	the	legal	context	of	the	CBD	as	one	example	in	which	the	term	is	used.	The	article	relates	this	use	of	the	term	to	the	biological	foundation	of	genetic	resources,	to	an	analysis	of	what	it	is	that	is	actually	been	used	as	a	resource	and	an	analysis	of	different	connotations	with	the	term	such	as	biodiversity	and	intellectual	property	rights	(IPR).	The	aim	is	to	present	a	comprehensive	interpretation	of	the	concept	of	genetic	resources,	which	can	consider	these	different	elements	of	the	analysis	and	which	fulfils	the	criteria	of	coherence	and	consistency.	A	‘coherent	interpretation’	is	understood	as	an	interpretation	without	any	logical	contradictions	and	a	‘consistent	interpretation’	is	understood	as	interpreting	a	concept	in	the	same	way	throughout	time	and	in	different	situations.		While	the	definition	of	‘genetic	resources’	has	been	discussed	in	the	policy	and	legal	context	(e.g.,	Ruiz	Muller,	2015;	Tvedt	&	Schei,	2013),	the	biological	perspective	on	the	concept,	including	its	biological	foundation	and	relation	to	biodiversity,	has	not	received	sufficient	attention	so	far.	One	aim	of	this	article	is	to	reinforce	engagement	with	this	concept	in	the	biological	community.	Conservation	biology	is	an	ideal	subdiscipline	to	start	such	a	discussion	for	several	reasons:	Conservation	biologists	are	usually	familiar	with	the	concept	from	the	CBD,	which	is	the	international	regulatory	framework	for	biodiversity	conservation.	Further,	due	to	its	applications	and	political	implications,	conservation	biology	has	a	long	tradition	of	interdisciplinary	discourse.	Moreover,	conservation	biologists	work	with	genetic	resources	in	the	context	of	biodiversity	and	thus	have	fundamental	and	practical	insights	into	their	use	and	value.	Finally,	conservation	biologists	have	an	interest	in	clarifying	the	scope	of	this	concept	because	as	users	of	genetic	resources,	they	are	expected	to	enter	ABS	negotiations	with	provider	states	when	such	resources	are	exported.	The	conditions	under	which	researchers	are	expected	to	enter	ABS	negotiations	is	not	only	a	legal	but	also	an	ethical	question.	It	is	part	of	good	scientific	practice	to	consider	these	issues	also	in	cases	when	there	is	no	legal	requirement,	for	instance,	because	the	provider	state	is	not	a	party	to	the	CBD.		The	article	begins	with	a	brief	introduction	to	the	historical	roots	of	the	concept.			
1.1.	Historical	roots	of	the	concept	The	history	of	the	concept	‘genetic	resources’	can	be	traced	back	to	at	least	the	1970s	and	1980s,	when	it	appeared	in	the	context	of	agricultural	plants.	In	a	1975	Science	article	entitled	“Our	Vanishing	Genetic	Resources”,	Jack	Harlan	deplored	that	novel	trends	in	agriculture	result	in	the	reduction	of	cultivated	crop	varieties	and	highlighted	the	importance	of	collections	to	conserve	genetic	diversity	(Harlan,	1975).	Based	on	the	same	concerns,	the	International	Board	for	Plant	Genetic	Resources	(IBPGR)	was	
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founded	in	1974.2	In	1983,	the	Food	and	Agriculture	Organisation	(FAO)	of	the	United	Nations	established	the	Commission	on	Genetic	Resources	for	Food	and	Agriculture,	which	is	responsible	for	issues	related	to	genetic	resources	in	an	agricultural	context.	These	early	institutional	endeavours	conceived	genetic	resources	as	the	common	heritage	of	mankind.3	However,	the	notion	that	genetic	resources	represent	humanity’s	common	heritage	has	been	strongly	criticised.	Pat	Mooney,	for	instance,	argued	that	there	was	a	“gene	drain”	from	the	global	South	towards	the	North,	which	was	exploited	by	the	latter.	He	writes:	“The	South	has	been	donating	this	material	in	the	belief	that	its	botanical	treasures	form	part	of	the	‘Common	Heritage’	of	all	humanity.	Meanwhile,	the	North	has	been	patenting	the	offshoots	of	this	common	heritage	and	is	now	marketing	its	new	varieties,	at	great	profit,	around	the	world”	(Mooney,	1983:	p3).	This	concern	has	been	supported	by	so-called	biopiracy	cases,	in	which	unauthorised	companies	in	the	North	accessed	genetic	resources	and	traditional	knowledge	from	the	global	South		(Reid,	2009).	Together	with	increased	expectations	of	financial	profits	from	genetic	resources,	these	concerns	led	to	a	paradigm	shift,	whereby	access	to	genetic	resources	fell	under	the	authority	of	state	sovereignty.4		The	most	influential	document	for	the	current	understanding	of	genetic	resources	is	the	CBD,	which	was	opened	for	signature	in	1992.	The	CBD	considers	different	types	of	organisms	in	its	definition	of	genetic	resources	as:	“genetic	material	of	actual	or	potential	value”,	and	genetic	material	as:	“any	material	of	plant,	animal,	microbial	or	other	origin	containing	functional	units	of	heredity”	(CBD,	article	2).	Although	not	explicitly	mentioned	in	this	definition,	the	CBD	omits	the	genome	of	Homo	sapiens	from	its	scope.5	This	convention	takes	up	the	discussion	on	who	should	be	able	to	benefit	from	genetic	resources	by	introducing	a	requirement	for	specific	ABS	procedures.	During	2010,	the	Conference	of	Parties	to	the	CBD	adopted	the	Nagoya	Protocol	(NP),	which	established	a	legal	framework	for	the	implementation	of	ABS.	The	Protocol	entered	into	force	in	October	2014,	and	had	been	ratified	by	some	100	states,	as	of	December	2017.	The	NP	adopts	the	definition	of	‘genetic	resources’	contained	in	the	CBD	and	specifies:	“‘Utilization	of	genetic	resources’	means	to	conduct	research	and	development	on	the	genetic	and/or	biochemical	composition	of	genetic	resources,	including	through	the	application	of	biotechnology	as	defined	in	Article	2	of	the	Convention”	(NP,	article	2).	The	term	has	thus	been	used	for	several	decades	in	different	contexts.	Nevertheless,	its	meaning	is	not	as	straightforward	as	this	standardised	use	might	imply,	which	is	the	starting	point	for	the	analysis	at	hand.																																																									2	Today,	IBPGR	works	under	the	name	Biodiversity	international	see:	http://www.bioversityinternational.org/about-us/who-we-are/history/	(accessed	December	2017)	3	This	was	explicitly	stated	in	“The	International	Undertaking	on	Plant	Genetic	Resources”.	See:	http://www.fao.org/docrep/x5563E/X5563e0a.htm#e.%20plant%20genetic%20resources%20(follow%20up%20of%20conference%20resolution%20681	(accessed	December	2017).	4	Annex	3	to	The	International	Undertaking	on	Plant	Genetic	Resources:	Resolution	3/91:	http://www.fao.org/docrep/x5587E/x5587e06.htm#e.%20commission%20on%20plant%20genetic%20resources%20and%20international%20undertaking:%20progress	(accessed	December	2017).	5	The	exclusion	of	human	genetic	resources	was	the	topic	of	several	COP	decisions	(https://www.cbd.int/decisions/cop/	(accessed	December	2017):	Decision	II/11	explicitly	“reaffirms	that	human	genetic	resources	are	not	included”.	The	Bonn	Guidelines	(adopted	in	Decision	VI/24)	mention	this	explicitly	in	their	General	Provisions	1C	(paragraph	9,	page	2).	Also,	in	the	discussion	of	different	options	in	the	International	Regime	on	Access	and	Benefit	Sharing,	“human	genetic	resources”	are	explicitly	excluded	when	the	scope	of	this	regime	is	described	(Decision	XIII/4,	Decision	IX/12).	Finally,	when	the	NP	was	adopted	at	COP	X	(decision	X/1)	the	parties	agreed,	bearing	in	mind	decision	II/11,	that	human	genetic	resources	are	not	included.		
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2.	Examples	of	using	genetic	resources	The	analysis	of	the	concept	of	‘genetic	resources’	in	this	article	sets	a	strong	focus	on	the	enquiry	of	what	it	is	that	is	actually	being	used	and	valued,	when	we	speak	of	using	genetic	resources	and	on	the	biological	foundations	of	these	resources.	In	the	following,	three	key	examples	of	using	genetic	resources	are	introduced	to	establish	a	starting	point	for	the	analysis	in	the	subsequent	chapters.	As	a	common	denominator,	all	of	these	examples	refer	in	one	way	or	another	to	biodiversity	as	something	that	is	valuable	and	they	have	been	discussed	as	typical	examples	of	using	genetic	resources.		
2.1.	Key	example	1:	Plant	genetic	resources	for	food	and	agriculture	As	stated	above,	the	first	discussion	of	genetic	resources	was	in	the	context	of	crops.	The	aim	of	plant	breeding	is	to	improve	and/or	combine	selected	characteristics	of	crops.	For	this	enterprise,	the	biological	diversity	of	varieties	with	different	properties	is	valuable.	Breeders	can	draw	upon	these	genetic	resources	to	adapt	cultivated	plants	to	novel	challenges	such	as	climate	change,	which	has	increased	the	need	for	draught-resistant	varieties	of	different	types	of	staple	food.	In	novel	crop	varieties,	for	instance,	drought-resistance	could	be	combined	with	other	desirable	traits,	such	as	high	yield	or	disease	resistance.	To	facilitate	the	exchange	of	seeds	or	other	plant	tissue	(germplasm)	the	FAO	established	a	multilateral	system	which	regulates	the	exchange	of	the	64	most	important	crops	in	the	food	sector,	independently	of	the	CBD’s	ABS	system	when	they	are	being	used	in	research,	breeding	and	training.6			
2.2.	Key	example	2:	Bioprospecting	With	the	establishment	of	the	CBD,	the	focus	of	the	concept	of	‘genetic	resources’	expanded	from	purely	agricultural	plants	to	include	other	organisms.	The	request	for	fair	and	equitable	ABS	in	the	CBD	seems	to	have	been	driven,	to	a	large	degree,	by	expectations	of	financial	benefits	from	bioprospecting	(Harvey	&	Gericke,	2011).	Bioprospecting	has	been	defined	as	“the	systematic	search	for	biochemical	and	genetic	information	in	nature	in	order	to	develop	commercially-valuable	products	[…]”.7	Some	authors	also	use	the	term	‘biodiscovery’	for	this	type	of	activity	(e.g.,	Robinson,	2014:	p4).	Typical	bioprospecting	projects	screen	collections	of	biological	extracts	for	medically	relevant	samples.	It	has	been	estimated	that	25-50%	of	marketed	drugs	are	based	on	natural	products	(Kingston,	2011).	In	consequence,	biodiversity	appeared	as	the	source	of	many	other	financially	lucrative	pharmaceuticals	in	the	future	and	has	resulted	in	high	expectations	in	biodiversity-rich	countries.			
2.3.	Key	example	3:	Basic	research	with	biological	samples	While	the	CBD	and	NP	were	drafted	primarily	with	commercial	research	in	mind	(e.g.,	bioprospecting),	most	utilisation	of	genetic	resources	seems	to	take	place	in	basic	research.8	Basic	research	with	biological	samples	is	performed	in	various	biological	sub-																																																								6	For	more	information	on	the	FAO’s	Multilateral	System	see:	http://www.fao.org/plant-treaty/areas-of-work/the-multilateral-system/overview/en/	(accessed	December	2017)	7	UNDP	definition	of	bioprospecting:	http://www.undp.org/content/sdfinance/en/home/solutions/bioprospecting.html		(accessed	December	2017)	8	The	ratio	between	commercial	and	non-commercial	utilisation	of	genetic	resources	can,	for	instance,	be	estimated	from	permits	for	access	to	genetic	resources	issued	by	countries	with	ABS	regulation.	Such	numbers	have	been	published	for	Australia,	which	in	five	years	(approximately	2010-2015)	was	reported	to	have	granted	about	450	permits,	only	10	of	which	included	potential	commercial	applications	
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disciplines	such	as	conservation	biology,	botany,	zoology,	ecology,	microbiology,	and	biochemistry	as	well	as,	for	instance,	in	the	medical	sciences	(e.g.	research	on	pathogens)	and	geosciences.	What	such	basic	research	projects	have	in	common	is	their	use	of	genetic	resources	to	collect	new	information	and	generate	knowledge.	Even	when	the	purpose	of	these	projects	is	theoretical,	with	the	aim	of	increasing	scientific	understanding,	some	information	may	be	of	practical	interest	for	future	commercial	applications	and	lead	to	follow-up	projects	with	applied	or	even	commercial	intent.	It	is	thus	impossible	to	draw	a	clear	line	between	commercial	and	non-commercial	research	in	general,	although	there	are	individual	research	projects	that	are	clearly	driven	by	commercial	incentives	and	others	that	are	clearly	motivated	only	by	the	desire	to	contribute	to	basic	research.	This	tight	connection	between	basic	and	commercial	research	complicates	ABS	negotiations	concerning	genetic	resources.		The	following	chapter	examines	the	resource	value	and	nature	of	genetic	resources	in	these	practical	examples.			
3.	Genetic	resources	as	a	particular	type	of	natural	resource	This	discussion	of	genetic	resources	as	a	particular	type	of	natural	resource	starts	from	a	broad	understanding	of	‘natural	resources’,	following	Margaret	Moore’s	definition	of	the	term	as	“anything	derived	from	the	environment	and	not	made	by	humans,	that	is	instrumental	to	satisfying	human	wants	and	needs.	They	are	part	of	the	‘natural	wealth’	of	the	world”	(Moore,	2015:	p163).	The	two	words	comprising	the	term	‘natural	resources’	characterise	its	meaning:	first,	‘natural	resources’	are	a	type	of	resources,	meaning	they	are	of	instrumental	value.	Second,	they	are	natural,	which	in	this	context	implies	that	they	have	not	been	produced	or	designed	by	humans.	If	a	product	has	been	generated	from	natural	resources,	the	latter	can	be	understood	as	a	natural	contribution	to	the	final	product.	Particularly,	the	second	and	third	key	examples	illustrate	that	genetic	resources	are	utilised	as	natural	resources,	as	something	derived	from	nature,	which	becomes	instrumentally	valuable	for	humans	to	generate	profits	and	other	benefits	including	scientific	knowledge.	In	accordance	with	this	understanding,	the	CBD	treats	genetic	resources	as	a	type	of	natural	resource	and	places	them	under	national	sovereignty	over	natural	resources	(CBD,	article	15).	Such	a	description	of	genetic	resources	as	natural	resources	raises	some	interesting	questions	concerning	domesticated	crops	(key	example	1).	Despite	the	expansion	of	the	definition	of	genetic	resources	beyond	crops,	they	remain	a	key	part	of	the	discussion	in	the	field;	however,	are	they	really	natural?	Humans	have	shaped	their	phenotypes	and	genotypes	through	selective	breeding	since	the	Neolithic	Period.	Thus,	humans	have	contributed	to	the	current	appearance	and	features	of	these	crops,	which	gives	them	a	non-natural	component.9	In	contrast,	these	crops	are	often	still	characterised	and	particularly	interesting	due	to	specific	natural	genes,	deriving	from	their	ancestor	plants.	Thus,	whether	we	use	crop	genetic	resources	as	natural	resources	(if	we	are	interested	in	specific	traits	originating	from	natural	plants)	or	as	human	products	(if	we	are	interested	in	a	variety’s	unnatural	combination	of	traits)	largely	depends	on	the	particular	utilisation.	Therefore,	if	we	understand	the	concept	‘genetic	resources’	as	referring	to	purely	natural	resources,	we	should	use	a	qualifier	such	as																																																																																																																																																																														(Schindel,	2010).	For	Brazil,	it	has	been	reported	that	for	the	period	of	2002-2013,	at	least	86.5	%	of	all	authorisations	concerned	scientific	research	in	contrast	to	authorisations	for	bioprospecting	or	technological	development	projects	(Gross,	2014:	p23).	9	Anthropologist	Darrell	A.	Posey	refers	to	a	similar	point	when	he	highlights	that	“biogenetic	resources”	are	often	modified	by	human	action	(e.g.,	in	Posey,	1995:	pp9,	20).		
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‘non-natural’	or	‘not	purely	natural’	in	the	context	of	crops	so	that	we	are	coherent	and	consistent	in	the	interpretation	of	the	concept.	Such	a	specification	may	help	explain	why	independent	regulation	such	as	the	ITPGRFA,	with	its	multilateral	system,	is	applied	for	this	particular	type	of	genetic	resources.	As	a	consequence	of	this	peculiarity,	an	independent	explanation	may	be	needed	for	placing	such	non-natural	genetic	resources	under	national	sovereignty.		
3.1.	The	non-material	nature	of	genetic	resources	As	items	that	are	instrumental	for	addressing	human	needs	and	desires	and	are	derived	from	nature,	genetic	resources	are	thus	a	type	of	natural	resource.	When	we	address	the	questions	of	what	exactly	is	the	resource	that	we	are	using	or	where	is	the	value	in	the	genetic	resources	being	imported	from	foreign	countries,	we	realise	that	there	is	one	crucial	difference	from	other	natural	resources	such	as	ores,	petroleum	or	timber.	While	in	the	latter	examples,	the	material	is	used	as	a	resource,	in	the	case	of	genetic	resources,	the	genetic	information	is	the	resource	being	used	and	valued.	In	the	following,	I	explain	this	point	in	more	detail:		The	utilisation	of	traditional	(material)	natural	resources	such	as	ores,	timber	or	petroleum	depends	on	the	material	processing	of	these	resources,	be	it	as	raw	material	in	manufacturing	procedures	or	as	a	provider	of	energy	in	a	combustion	process.	In	both	cases,	a	constant	supply	of	this	natural	resource	is	required	to	yield	further	benefits	and	profits.	In	contrast,	our	examples	illustrate	that	utilisation	of	genetic	resources	does	not	depend	on	such	material	supply	(see	also	Deplazes-Zemp,	2018).	Cases	of	plant	genetic	resources	in	traditional	crop	breeding	(key	example	1)	are	closest	to	the	classical	utilisation	of	natural	resources.	One	may	wonder	how	this	differs	from	utilising	biological	resources	such	as	timber	or	fish;	in	both	cases,	living	organisms	are	used	as	natural	resources.	However,	in	case	of	timber	or	fish,	benefits	and	profits	depend	on	the	amount	and	mass	of	the	biological	resource	that	can	be	yielded;	this	is	the	same	situation	as	for	other	material	natural	resources	such	as	ores	or	petroleum.	In	contrast,	profitable	utilisation	of	plant	genetic	resources	in	breeding	is	based	on	singular	plant	traits	(e.g.,	draught-resistance)	or	combinations	of	such	traits	that	could	be	crossed	into	commercial	varieties.	The	utilisation	of	genetic	resources	thus	requires	only	one	or	a	few	samples	of	the	original	resource	plant	in	question.	Once	the	new	trait	has	been	introduced	into	the	commercial	variety,	cultivating	this	new	variety	with	the	novel	genetic	combination	in	large	amounts	does	not	depend	on	further	supply	of	the	original	genetic	resource.	The	difference	also	applies	to	the	utilisation	of	genetic	resources	in	bioprospecting	(key	example	2).	As	described	above,	bioprospecting	projects	systematically	search	for	biological	samples	that	produce	a	desired	effect.	Once	the	users	of	this	resource	identify	such	a	sample,	they	isolate	the	compound	that	is	responsible	for	the	effect.	They	then	try	to	cultivate	the	plant	in	question	ex	situ	or	produce	the	compound	using	chemical	synthesis	or	genetically	modified	microorganisms;	as	a	result,	they	no	longer	depend	on	further	material	supply	of	the	plant	of	origin.	In	the	case	of	basic	research	with	biological	samples	(key	example	3),	it	also	is	information	that	is	valued	and	exported.		The	idea	of	the	informational	nature	of	genetic	resources	has	been	highlighted	by	other	authors	including	Christopher	Stone,	Joseph	Henry	Vogel	and	Manuel	Ruiz	Muller	(Ruiz	Muller,	2015;	Stone,	1995;	Vogel,	1994).	The	latter	two	have	tried	in	vain	to	bring	this	point	of	view	into	the	CBD	(Ruiz	Muller,	2015).	They	have	addressed	the	issue	from	the	point	of	view	of	economists,	relating	genetic	information	to	the	‘economics	of	information’	(Oduardo-Sierra,	et	al,	2012),	and	aim	to	understand	benefits	from	genetic	resources	and	how	they	can	be	turned	into	incentives	for	biodiversity	conservation.	A	
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particular	focus	of	these	authors	lies	in	integrating	their	analyses	of	genetic	resources	into	an	explicit	model	of	attributing	property	rights	(Ruiz	Muller,	2015;	Vogel,	1994;	Vogel	et	al.,	2011).	In	the	article	at	hand,	the	phrase	‘informational	resources’	is	used	rather	than	Vogel’s	phrase	‘genetic	resources	as	natural	information’	because	the	goal	here	is	to	emphasise	the	informational	character	of	genetic	resources;	the	question	of	their	naturalness	is	discussed	separately.	Moreover,	this	article	aims	at	explaining	the	particular,	informational	nature	of	genetic	resources	based	on	an	analysis	of	how	value	is	generated	from	them	and	with	reference	to	their	biological	foundation.	A	conclusion	about	the	informational	nature	of	genetic	resources	has	thus	been	drawn	here,	independent	of	the	economic	models	suggested	by	Vogel,	Ruiz	Muller	and	others,	but	in	agreement	with	their	theoretical	assumptions.		From	a	biological	point	of	view,	the	argumentation	for	the	informational	nature	of	genetic	resources	is	straightforward.	The	genome	carries	the	blueprint	of	the	organism	in	question	in	the	form	of	DNA	or	RNA.	The	biological	function	of	these	nucleic	acids	lies	in	the	information	that	they	contain	in	the	sequence	of	the	four	nucleobases—adenine,	guanine,	cytosine	and	thymine/uracil.	‘Genetic	information’	is	a	common	phrase	in	biology;	therefore,	the	idea	that	genetic	resources	are	informational	will	be	intuitive	for	most	biologists.	However,	it	could	be	countered	that	this	understanding	of	‘genetic	resources’	is	too	‘biologistic’	and	reductionist	in	nature.	Critics	could	argue	that	long	before	the	genome	of	these	organisms	was	sequenced,	or	even	before	it	was	known	that	nucleic	acids	are	the	carriers	of	genetic	information,	genetic	resources	were	utilised.	They	were	exchanged	as	biological	materials,	for	instance,	as	individual	crop	plants	or	seeds,	or	they	were	‘stolen’,	for	example,	by	scientists	collecting	material	samples	of	different	species	in	the	rainforest.	This	objection,	however,	cannot	refute	the	fact	that	genetic	resources	are	informational,	because	as	explained	above,	the	utilisation	and	value	of	these	samples	relies	on	the	intangible	information	that	they	carry	rather	than	on	their	material,	even	if	it	is	material	samples	that	have	been	collected,	exported,	exchanged	or	stolen.			
3.2.	Practical	consequences	of	the	non-material	nature	of	genetic	resources	The	interpretation	of	‘genetic	resources’	suggested	above	contradicts	the	CBD’s	reference	to	material	in	its	definition	of	genetic	resources	as	“genetic	material	of	actual	or	potential	value”.	Genetic	material	in	the	sense	of	material	nucleic	acids	is	not	of	interest	to	users;	it	is	always	the	information	carried	by	this	material	that	is	valuable.	Therefore,	this	definition	reflects	neither	the	real	value	of	genetic	resources	nor	their	biological	function	nor	how	genetic	resources	are	actually	being	used.	To	harmonise	the	CBD’s	definition	of	‘genetic	resources’	with	the	resource	value,	resource	utilisation	and	biological	foundation	of	this	type	of	resource,	it	would	be	necessary	to	adapt	the	original	text	of	the	CBD	such	that	it	acknowledges	the	fact	that	the	value	of	genetic	resources	lies	not	in	their	material	but	in	sought-after	information.	The	request	for	an	analogous	adaptation	has	been	brought	forward	by	Vogel	and	colleagues	for	many	years	but	so	far	has	not	been	considered	(Ruiz	Muller,	2015).	This	non-consideration	can	be	explained	pragmatically,	by	the	argument	that	the	COP’s	main	priorities	must	lie	in	implementing	its	key	objectives	in	light	of	upcoming	challenges	rather	than	renegotiating	basic	definitions.	However,	based	on	my	previous	analysis	this	should	not	be	used	as	an	excuse	to	ignore	the	fact	that	it	is	the	informational	value	of	genetic	resources	to	which	ABS	applies.	The	purpose	of	this	article	is	to	raise	the	awareness	of	this	important	point	in	the	biological	community.	While	this	may	contribute	to	a	revision	of	the	definition	in	the	CBD	in	the	long	term,	in	the	short	term,	the	main	aim	is	to	bring	this	perspective	into	the	discussion	of	how	the	NP	should	be	implemented	in	concrete	cases.	The	pragmatic	
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short-term	recommendation	is	thus	to	set	a	stronger	focus	on	the	NP’s	definition	of	‘utilisation	of	genetic	resources’,	which	refers	to	conducting	“research	and	development	on	the	genetic	and/or	biochemical	composition	of	genetic	resources”.	This	could	serve	as	the	starting	point	to	harmonise	regulation	of	genetic	resources	with	their	practical	utilisation	as	information,	in	spite	of	inconsistencies	regarding	how	they	have	been	defined	in	the	CBD.		Morton	Walloe	Tvedt	and	Peter	Johan	Schei	suggested	a	similar	compromise	between	a	definition	of	genetic	resources	that	refers	to	their	material	and	the	actual	use	of	their	information.	Rather	than	insisting	on	the	non-material	nature,	these	authors	refer	to	a	broad	interpretation	of	‘genetic	material’	in	the	CBD	and	NP	that	includes	material	as	well	as	“intangible,	informational	elements”	(Tvedt	&	Schei,	2013:	p21).	While	such	an	approach	could	be	successful	in	bringing	the	consideration	of	the	informational	nature	of	genetic	resources	into	the	policy	discussion,	it	is	argued	here	that	to	understand	the	particular	features	of	genetic	resources	and	to	integrate	them	into	a	coherent,	consistent	and	comprehensive	picture	it	is	important	to	be	aware	of	the	problem	with	reference	to	material	in	the	CBD	definition.	The	question	of	how	to	consider	the	informational	nature	of	genetic	resources	is	very	topical	in	view	of	novel	technological	developments	that	offer	new	possibilities	of	working	with	genetic	information.	Examples	of	such	developments	are	first,	the	utilisation	of	digital	sequences	in	synthetic	biology,	which	is	currently	being	debated	as	a	potential	form	of	using	genetic	resources,	and	second,	environmental	DNA	(eDNA),	which	has	not	yet	received	much	attention	in	this	context	but	is	of	particular	interest	in	conservation	biology.			
3.3.	Controversial	example	1:	Synthetic	biology		The	term	‘synthetic	biology’	is	used	for	different	approaches	aimed	at	introducing	rational	design	or	engineering	strategies	into	biology	(Deplazes,	2009).	This	discipline	works	with	genetic	material,	but	it	is	often	not	full	genes	but	rather	gene	fragments	or	regulatory	sequences	that	are	of	interest.	Thanks	to	rapid	technological	progress	in	DNA	synthesis,	tangible	genetic	materials	can	now	be	synthesised	based	on	the	genetic	sequence	without	the	need	to	import	materials	from	other	countries.	The	digital	code	of	a	gene	of	interest	is	sufficient	for	using	this	genetic	resource.	The	extent	to	which	this	handling	of	genetic	data	is	covered	by	the	NP	has	been	critically	discussed,	for	instance,	at	the	13th	UN	Biodiversity	Conference	COP	13	in	Cancun	in	December	2016.10	A	central	question	was	whether	the	NP	applies	only	to	tangible	genetic	materials	or	whether	digital	sequences	are	included	(Baglay,	2015;	CBD,	2008;	Tvedt	&	Schei,	2013).	Concerns	were	brought	forward	that	unauthorised	use	of	digital	sequences	from	genetic	resources	would	amount	to	‘digital	biopiracy’	(ICSWGSB,	2016).	The	parties	at	the	COP	13	did	not	come	to	an	agreement	as	to	how	to	deal	with	genetic	fragments	or	digital	sequences	at	the	international	level.11	Nevertheless,	certain	countries,	for	instance,	Brazil,	already	include	‘information	of	genetic	origin’	in	their	ABS	regime	(Baglay	&	Rai,	2013:p20;	Manheim,	2016).	Likewise,	the	Andean	Community’s	Common	Regime	on	Access	to	
																																																								10	For	more	information,	see	the	summary	of	this	conference	at	http://www.iisd.ca/biodiv/cop13/enb	(accessed	December	2017).	11	In	the	CBD’s	online	Forum	on	Synthetic	Biology,	Joseph	Henry	Vogel	initiated	an	interesting	discussion	with	his	criticism	that	the	AHTEG	definition	of	synthetic	biology	does	not	refer	to	the	informational	nature	of	genetic	resources,	which	confirms	that	the	importance	of	this	aspect	has	not	yet	been	generally	acknowledged	http://bch.cbd.int/synbio/open-ended/discussion/?threadid=8367	(accessed	December	2017).	
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Genetic	Resources	(comprising	Bolivia,	Columbia,	Ecuador	and	Peru)	includes	‘intangible	components’	in	their	definition	of	access	to	genetic	resources.12		The	synthetic	biology	example	will	be	discussed	in	light	of	the	interpretation	of	genetic	resources	as	informational	natural	resources	after	a	brief	introduction	of	the	second	controversial	example:			
3.4.	Controversial	example	2:	eDNA		Research	using	eDNA	is	another	example	of	a	novel	technological	development	that	leads	to	new	and	sometimes	unpredictable	modes	of	utilising	biological	information.	The	phrase	‘eDNA’	describes	DNA	fragments	that	can	be	extracted	from	air,	water	or	other	environmental	samples	and	thus	without	direct	contact	to	the	living	organism	from	which	they	originate	(Baird	&	Hajibabaei,	2012).	Often,	these	eDNA	fragments	have	been	degraded	but	still	enable	conclusions	to	be	drawn,	for	instance,	about	the	composition	of	organisms	that	lived	along	riversides	(Deiner	et	al.,	2016).	The	utilisation	of	eDNA	may	become	relevant	in	biodiversity	research	(Thomsen	&	Willerslev,	2015)	and	is	thus	also	interesting	for	conservation	biologists.	Besides	the	question	of	how	to	deal	with	samples	that	are	being	collected	detached	from	the	original	organism,	this	example	raises	similar	issues	as	the	case	of	synthetic	biology.	Again,	it	is	not	clear	whether	research	involving	sequencing	results	of	air	or	water	samples	should	count	as	‘utilisation	of	genetic	resources’	and	thus	be	subject	to	ABS.			 These	two	examples	are	controversial	with	respect	to	the	question	of	whether	genetic	resources	are	being	used	in	work	with	digital	sequences.	Based	on	a	literal	reading	of	the	CBD’s	definition	of	‘genetic	resources’,	it	could	be	argued	that	the	use	of	digital	sequences	should	not	count	as	using	genetic	resources	because	it	does	not	involve	biological	material.	However,	with	a	focus	on	the	NP’s	definition	of	‘utilising	genetic	resources’,	it	can	be	reasoned	that	work	with	digital	sequence	is	a	form	of	conducting	research	on	the	genetic	composition	of	genetic	resources,	which	falls	into	the	scope	of	the	definition.	Likewise,	the	interpretation	of	genetic	resources	developed	in	this	article,	according	to	which	they	are	an	informational	type	of	natural	resource,	suggests	that	both	controversial	examples	are	cases	of	using	the	informational	resource	value	of	genetic	resources.		However,	even	if	we	acknowledge	that	a	coherent	and	consistent	interpretation	of	the	concept	of	‘genetic	resources’,	as	developed	in	this	article,	leads	to	the	conclusion	that	research	with	digital	sequences	is	a	form	of	resource	utilisation,	there	may	be	
specific	reasons	not	to	include	them	in	the	regulatory	ABS	framework.	By	a	specific	reason	I	mean	a	reason	that	leads	to	the	adaptation	of	a	general	rule	to	take	into	consideration	particular	practical	challenges	in	certain	situations.	For	instance,	there	are	rules	(in	the	sense	of	laws)	for	car	drivers	in	road	traffic.	However,	for	certain	specific	reasons,	there	are	exceptions	to	these	general	rules	for	police	cars	in	emergency	situations.	As	will	be	discussed	in	the	next	section,	specific	reasons	can	be	brought	forward	to	explain	why	human	genetic	resources	are	not	included	in	the	ABS	framework.	With	respect	to	research	on	digital	sequences,	some	specific	reasons	that	might	be	brought	forward	to	argue	for	exemption	include	the	impossibility	of	controlling	access	to	digital	sequences	and	the	administrative	burden	that	would	follow	from	a	request	of	ABS	in	these	cases.	Moreover,	it	might	be	argued	that	there	would	be	negative	consequences	for	the	actual	aims	of	the	CBD	with	respect	to	biodiversity	conservation,	when	any	type	of	research	with	digital	DNA	libraries,	for	instance,	in	barcoding	projects,																																																									
12 Decision	391–Common	Regime	on	Access	to	Genetic	Resources,	Article	I:	http://www.wipo.int/wipolex/en/details.jsp?id=9446	(accessed	December	2017).	
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would	have	to	undergo	ABS	negotiations	(see	section	4.4).	However,	this	article	is	not	the	place	to	scrutinize	these	reasons	or	to	make	any	suggestions	as	to	whether	they	are	important	and	convincing	enough	to	grant	such	an	exception	from	ABS	regulation.		The	reader	may	wonder	why	so	much	emphasis	is	placed	on	the	informational	nature	of	genetic	resources	in	this	article	when	it	eventually	allows	for	the	possibility	to	exclude	the	use	of	digital	sequences	as	‘pure	information’	from	the	scope	of	the	ABS	framework	for	specific	reasons.	My	motive	to	refer	to	specific	reasons	here	is	twofold.	First,	it	is	important	to	clarify	that	from	the	conclusion	that	the	use	of	digital	sequences	is	a	form	of	utilising	genetic	resources	it	does	not	necessarily	follow	that	they	must	be	subject	to	ABS	regulation.	The	question	of	what	this	conclusion	means	for	the	regulation	of	digital	sequences	must	be	discussed	separately.	Second,	it	follows	from	my	conclusion	that	if	the	use	of	digital	sequences	is	excluded	from	ABS	regulation,	this	exclusion	cannot	be	justified	with	the	argument	that	digital	sequences	are	not	a	form	of	using	genetic	resources.	Instead,	such	an	exception	would	have	to	be	based	on	specific	reasons,	which	would	have	to	be	scrutinized	for	their	persuasiveness.	If	it	is	transparent	that	the	exception	is	granted	based	on	specific	reasons,	this	will	clarify	that	other	requests	for	exceptions	must	be	based	on	new	and	convincing	specific	reasons.	Moreover,	exceptions	may	be	revoked	in	light	of	new	specific	reasons.		The	aim	of	adhering	to	a	coherent	and	consistent	interpretation	of	the	concept	of	‘genetic	resources’	is	thus	compatible	with	taking	into	account	specific	practical	challenges	in	different	types	of	resource	use.	The	following	chapter	supports	this	claim	with	the	discussion	of	a	type	of	genetic	resources	that	has	generally	been	accepted	as	an	exception	with	respect	to	ABS	regulation.	
	
3.5.	Genetic	resources	and	the	human	genome	As	indicated	earlier,13	human	genetic	resources	have	been	omitted	from	the	framework	of	the	CBD	and	NP,	and	the	term	‘genetic	resources’	is	usually	applied	in	the	context	of	non-human	genomes.14	However,	there	seems	to	be	no	convincing	reason	why	the	human	genome	should	not	be	considered	a	type	of	genetic	resources.	The	human	genome	is	not	only	the	same	with	respect	to	its	biological	function	and	composition,	but	to	a	large	extent,	DNA	sequences	of	the	human	genome	and	genomes	from	other	organisms	are	identical.	Human	genetic	resources,	like	other	genetic	resources,	are	used	as	a	natural	resource	when	lucrative	products	are	generated	in	the	pharmaceutical	industry,	for	instance,	genetic	tests	or	medical	treatments.	Human	and	non-human	genetic	resources	are	thus	comparable	with	respect	to	function,	content	and	how	benefits	are	produced.	However,	although	human	genetic	resources	and	their	utilisation	are	not	different	from	other	types	of	genetic	resources,	there	are	good	specific	reasons	to	treat	this	type	of	genetic	resources	exceptionally.	Such	reasons	include	differences	in	the	disciplinary	and	regulatory	contexts	of	resource	use.	The	national	and	international	institutions	and	treaties	that	address	agriculture	and	environmental	conservation	are	different	from	those	concerned	with	human	health,	which	is	the	context	in	which	the	human	genome	is	of	interest.	Moreover,	the	specific	relations	that	humans	have	to	human	genetic	resources	provide	good	reasons	to	treat	and	regulate	the	human	genome	differently	from	other	genetic	resources	(Schroeder	&	Lasen-Diaz,	2006).	The	difference	between	the	two	types	of	genetic	resources	became	particularly	relevant	with	the	shift	from	the	common	heritage	model	to	the	idea	of	state	sovereignty	over	genetic	resources																																																									13	See	footnote	5	14	Authors	who	previously	discussed	benefit	sharing	from	genetic	resources	alongside	the	situation	of	the	human	genome	include:	(Dauda	&	Dierickx,	2013;	Schroeder	&	Lasen-Diaz,	2006;	Schuklenk	&	Kleinsmidt,	2006).		
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as	declared	in	the	CBD.	Speaking	of	sovereignty	over	human	genetic	resources	does	not	make	sense	because	Homo	sapiens	can	be	found	in	every	state.	Moreover,	state	sovereignty	over	individual	(or	subgroup)	genetic	variations	would	be	highly	problematic	for	ethical	reasons,	because	of	the	particular	relations	of	the	concerned	individuals	to	their	material	DNA	samples	and	the	genetic	information	that	it	contains.		In	the	case	of	the	human	genome,	an	exception	on	specific	grounds	has	thus	been	well	established	and	illustrates	that	it	is	possible	to	grant	exceptions.	Although,	or	particularly,	because	human	genetic	resources	are	naturally	treated	as	an	exception,	it	is	important	to	raise	awareness	of	the	fact	that	human	genetic	resources	are	just	as	much	a	type	of	informational	natural	resources	as	non-human	ones.	Therefore,	it	seems	advisable	to	speak	explicitly	of	non-human	genetic	resources	in	the	context	of	the	CBD.	This	clarification	brings	out	those	practical	aspects,	which	are	similar	in	the	human	and	non-human	contexts,	for	instance,	the	question	of	patentability	of	genetic	sequences	(see	section	5).	
	
4.	Genetic	resources	and	biodiversity	The	previous	chapter	attempted	to	characterise	genetic	resources	as	an	informational	type	of	natural	resource,	starting	from	an	analysis	of	how	genetic	resources	are	actually	being	used	and	valued	and	taking	into	account	the	biological	function	of	genetic	information.	This	chapter	addresses	another	dimension	of	the	concept	of	‘genetic	resources’,	namely	its	connection	to	biodiversity.	This	important	aspect	has	often	receded	into	the	background	when	the	definition	of	‘genetic	resources’	is	being	discussed	with	a	particular	focus	on	the	legal	and	economic	implications.	It	is	thus	important	to	raise	conservation	biologists’	awareness	of	the	discussion	of	this	concept	hoping	that	this	will	motivate	them	to	contribute	to	the	discussion	and	give	the	biodiversity	aspect	more	weight.	The	term	‘genetic	resources’	was	coined,	after	all,	to	demonstrate	that	biodiversity	is	instrumentally	valuable	and	thus	has	resource	character,	as	illustrated	by	Jack	Harlan’s	plea	in	1975	introduced	above	(Harlan,	1975)	and	the	central	role	that	this	concept	plays	in	the	CBD.	This	chapter	examines	how	the	concept	of	‘genetic	resources’	relates	biodiversity	to	natural	resources	and	which	specific	resource	characteristics	result	from	this	relation.		
4.1.	Biodiversity	as	a	natural	resource	The	instrumental	value	or	resource	character	of	biodiversity	and	thus	its	relation	to	what	was	described	in	the	previous	chapter	is	not	obvious.	For	instance,	Donald	S.	Maier	explicitly	denied	this	relation	in	his	provocatively	titled	book,	“What	is	so	good	about	biodiversity”	(Maier,	2013).	He	argues,	amongst	other	things,	that	the	idea	of	a	particular	value	of	biodiversity	as	genetic	resources	is	inaccurate	because	it	is	singular	species	and	not	biodiversity	as	a	whole	that	serve	as	natural	resources	and	provide	benefits	(Maier,	2013:	pp163ff,	196ff).	According	to	such	an	understanding,	biodiversity	is	an	accumulation	of	individual	examples	of	genetic	resources	in	the	form	of	resourceful	genes	or	genomes.	Even	in	this	interpretation,	it	can	be	argued,	in	contradiction	to	Maier,	that	biodiversity	as	a	whole	is	valuable	as	a	resource	because	we	do	not	yet	know	the	relevant	genes/genomes	that	will	be	identified	as	instrumental	in	the	future.	This	is	the	idea	exploited	in	bioprospecting	(key	example	2),	and	can	be	found	in	the	CBD’s	definition	of	‘biological	resources’,	when	it	refers	not	only	to	their	actual	but	also	their	
potential	value	for	humanity.	Besides	this	understanding	of	biodiversity	as	a	source	of	not-yet-identified	instrumental	value,	there	are	other	understandings	that	attribute	the	value	to	the	diversity	itself.	In	these	views,	biodiversity	is	seen	as	a	source	for	future	development	of	new	combinations,	new	genomes,	species	and	ecosystems,	be	it	through	
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natural	evolution	or	technological	combination.	Here,	it	is	the	diversity	itself	that	is	the	resource	because	it	is	the	source	of	something	new.	Likewise,	diversity	of	genetic	traits	allows	a	population	or	ecosystem	to	deal	with	novel	challenges,	which	leads	to	the	argument	that	biodiversity	is	valuable	because	it	provides	resilience.	Finally,	in	academic	projects	studying	interactions	in	and	compositions	of	ecosystems,	it	is	often	the	diversity	itself,	not	only	the	individual	organisms	or	species,	which	is	of	interest.	Drawing	on	these	interpretations,	we	can	understand	the	concept	of	‘genetic	resources’	as	a	particular	appreciation	not	only	of	the	information	in	individual	genomes	but	also	of	biodiversity	in	general	as	a	natural	resource.	This	interpretation	also	refers	to	the	informational	nature	of	genetic	resources,	since	it	is	not	the	material	in	biodiversity	that	is	of	value	but	the	plethora	of	information	that	it	contains.			
4.2.	The	need	for	protection	The	connection	of	genetic	resources	to	biodiversity	reveals	another	feature,	namely	their	particular	vulnerability.	Traditional	natural	resources	can	be	divided	into	three	categories:	non-finite	resources,	such	as	wind	or	solar	energy;	and	two	forms	of	finite	resources,	namely	renewable	resources,	such	as	fisheries	and	timber;	and	non-renewable	resources,	such	as	ores,	coal	and	petrol.	Genetic	resources	cannot	be	integrated	into	this	classification.	As	informational	resources,	they	are	not	finite	in	the	sense	that	resource	stocks	are	depleted	by	overuse.	However,	they	are	destructible	by	means	other	than	resource	utilisation,	which	makes	them	even	more	vulnerable	than	non-renewable	resources.	This	aspect	of	genetic	resources	is	particularly	prevalent	in	the	discussion	of	genetic	resources	as	biodiversity.	The	on-going	loss	of	biodiversity	has	been	deplored	not	only	because	of	the	loss	of	instrumental	genetic	resources	but	also	because	of	the	potential	intrinsic	value	of	biodiversity,	as	declared,	for	example,	in	the	CBD,	and	because	of	the	environmental	consequences	for	humans	and	the	rest	of	nature.	The	fact	that	it	is,	to	a	large	degree,	the	industrialised	human	lifestyle	that	has	triggered	the	on-going	loss	of	biodiversity,	could	lead	to	environmental	responsibilities	that	go	beyond	sustainable	use	towards	active	protection	of	biodiversity.	These	particular	responsibilities	must	be	taken	into	account	in	a	comprehensive	discussion	on	genetic	resources,	and	they	are	the	main	background	against	which	ABS	for	genetic	resources	has	been	integrated	into	the	CBD.	Another	consequence	of	the	need	for	protection	in	the	context	of	genetic	resources	is	the	incurrence	of	opportunity	costs	when	protection	of	biodiversity	is	accompanied	by	a	decrease	in	yield	for	those	who	use	land	in	a	sustainable	way	or	abstain	from	using	it	altogether.	Ethical	and	policy	reflections	on	genetic	resources	that	aspire	to	comprehensiveness	must	consider	these	particular	responsibilities	and	the	occurrence	of	opportunity	costs	related	to	the	vulnerability	of	genetic	resources	as	biodiversity.		
4.3.	Scientific	benefits		As	a	type	of	natural	resource,	genetic	resources	are	used	to	create	benefits.	The	third	key	example	(academic	research	in	general)	and	the	second	controversial	example	(eDNA)	introduced	earlier	illustrate	that	basic	research	is	one	of	the	main	utilisations	of	genetic	resources	and	that	research	projects	studying	biodiversity	including	conservation	biology	studies	play	an	important	role	in	this	context.	The	resulting	benefits	are	of	a	different	nature	than	benefits	from	classical	natural	resources,	be	it	petrol,	ores,	diamonds,	fisheries	or	timber,	which	are	fungible	and	can	be	quantified	by	monetary	substitutes.	In	contrast,	monetary	value	is	not	usually	assigned	to	gains	from	research	that	has	not	been	commercialized.	Scientific	findings	deriving	from	genetic	resources	are	valuable	for	other	researchers	in	the	field	and	increases	the	prestige	of	the	scientists	and	
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institutions	involved.	In	addition,	new	information	about	biodiversity	could	be	of	particular	interest	for	local	people	in	the	study	area	and	for	other	societies.	Finally,	it	is	important	for	nature	conservation	projects	and	ideally	contributes	to	the	protection	of	biodiversity.	In	this	sense,	genetic	resources	produce	different	types	of	non-commutable	benefits	for	different	interest	groups.	The	appendix	of	the	NP	includes	a	list	of	potential	benefits	from	genetic	resources	that	could	be	shared,	which	indicates	that	there	is	awareness	of	the	special	benefits	that	result	from	research	on	genetic	resources.	Again,	this	particularity	of	genetic	resources	with	respect	to	the	resulting	benefits	explains	why	they	are	different	from	other	types	of	natural	resource,	which	are	utilised	mainly	for	monetary	profits.		To	relate	these	particular	features	of	genetic	resources	as	biodiversity	more	directly	to	the	utilisation	of	genetic	resources	and	to	the	previous	chapters,	conservation	biology	is	discussed	as	a	biodiversity	example	of	genetic	resource	use:		
4.4.	Biodiversity	example	1:	Conservation	biology		Conservation	biology	is	an	applied	science	with	the	aim	of	producing	scientific	benefits	for	biodiversity	conservation.	Most	research	in	conservation	biology	involves	the	use	of	genetic	resources,	whenever	organisms	are	being	studied.	As	a	type	of	conservation	biology	that	focuses	on	genetic	information	detached	from	material	organisms,	conservation	genetics	raises	issues	comparable	to	the	controversial	examples	discussed	above.	In	this	field,	researchers	study,	for	instance,	deleterious	effects	of	inbreeding,	loss	of	genetic	diversity,	accumulation	of	deleterious	mutations,	genetic	adaptation	and	many	other	genetic	phenomena	to	gain	a	better	understanding	of	which	genetic	factors	may	play	a	role	in	the	extinction	risk	of	a	species	and	how	such	risks	can	be	minimised	(Frankham	et	al.,	2010:	pp8ff).	More	recently,	genomic	approaches	have	also	found	their	way	into	conservation	biology	(McMahon	et	al.,	2014;	Shafer	et	al.,	2015).	Interestingly,	genetic	diversity	within	species	is	also	a	direct	and	specific	target	of	biological	conservation,	to	which	the	CBD	explicitly	refers	in	its	definition	of	‘biological	diversity’.	The	importance	of	this	aspect	of	biodiversity	is	recognised	in	the	strategic	plan	of	the	CBD	in	Aichi	Target	13,	which	states	that	the	genetic	diversity	of	domesticated,	farmed	and	other	socio-economically	and	culturally	valuable	species	should	be	safeguarded,	and	their	genetic	erosion	minimised.15	Besides	conservation	genetics	and	genomics	the	controversial	examples	of	using	genetic	resources	introduced	above,	eDNA	and	synthetic	biology,	could	also	play	a	role	in	conservation	biology.	Environmental	DNA	could	serve	as	a	tool	to	monitor	biodiversity	(Thomsen	&	Willerslev,	2015),	and	it	has	been	suggested	that	synthetic	biology	could,	for	instance,	be	used	to	introduce	resistance	to	biological	threats	for	endangered	species	or	to	control	invasive	species	(Redford	et	al.,	2013).	DNA	barcoding	is	another	tool	that	involves	digital	sequences	and	is	directly	used	to	monitor	genetic	diversity	and	in	conservation	genetics	research.	These	barcodes	consist	of	short	digital	DNA	sequences,	by	which	species	can	be	rapidly	identified	(e.g.,Bruford	et	al.,	2017;	Hebert	et	al.,	2003;	http://www.ibol.org	(accessed	December	2017).	The	use	of	direct	genetic	information,	which	may	be	detached	from	the	original	organism,	thus	becomes	increasingly	influential	in	conservation	biology	as	well	and	may	lead	to	controversy	as	to	whether	this	should	count	as	using	genetic	resources	and	whether	it	should	be	subject	to	ABS	regulation.		
																																																									15	For	the	Aichi	Biodiversity	Targets	see:	https://www.cbd.int/sp/targets/default.shtml	(accessed	December	2017)	
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5.	Genetic	resources	and	intellectual	property	rights	Whether	IPR	and	the	idea	of	ABS	can	and	should	be	combined	has	been	controversially	discussed.	Concerns	that	the	CBD	could	weaken	IPR	were	reported	as	one	of	the	main	reasons	why	the	US	administration	did	not	sign	it	in	1992	(Gepts,	2004;	McManis,	1998).	However,	other	authors	have	suggested	that	the	idea	of	ABS	is	compatible	with	IPR	(Gepts,	2004;	McManis,	1998),	or	that,	if	implemented	intelligently,	IPR	can	complement	the	CBD’s	aims	by	providing	incentives	for	biodiversity	conservation	(Lawson,	2009;	Ruiz	Muller,	2015;	Stone,	1995;	Vogel,	1994).	The	practical	connection	between	ABS	and	IPR	is	that	potential	profits	resulting	from	IPR	related	to	genetic	resources	are	amongst	the	central	benefits	to	be	negotiated	in	ABS.	The	reason	to	address	the	relation	between	ABS	and	IPR	in	this	analysis	of	the	concept	of	genetic	resources	is	that	the	role	of	IPR	in	this	discussion	is	linked	to	the	particular	features	of	genetic	resources	described	above.	The	connection	between	genetic	resources	and	IPR	may	at	first	seem	like	a	paradox.	How	can	something	be	discussed	at	the	same	time	as	a	natural	resource	and	as	an	object	of	IPR,	such	as	patents,	which	are	traditionally	issued	explicitly	for	something	that	is	not	natural	but	a	human	invention?	This	chapter	seeks	to	address	this	apparent	paradox	and	to	show	why	IPR	came	to	play	such	an	important	role	in	the	debate	and	legislation	surrounding	genetic	resources.			
5.1.	Property	rights	for	information		Let	us	start	with	the	very	general	question	of	what	kind	of	property	rights	are	appropriate	for	genetic	resources.	Such	rights	would	have	to	consider	the	non-tangible	informational	nature	of	this	type	of	resource.	Information	can	be	multiplied	and	used	in	different	material	and	non-material	forms	without	the	knowledge	of	the	provider.	It	is	thus	in	the	very	nature	of	genetic	resources	that	they	are	non-rivalrous,	meaning	that	the	utilisation	of	genetic	resources	by	one	does	not	hinder	others	from	using	them.	Access	to	genetic	resources	cannot	be	regulated	by	property	rights	over	material	supplies.	If	we	thus	want	to	assign	property	or	control	rights	over	genetic	resources,	a	new	type	of	rights	for	natural	information	is	needed.	This	could	be	a	general	agreement	that	providers	of	genetic	resources	have	a	right	to	exclude	others	from	using	‘their’	natural	information	or	to	sell	licences	that	allow	its	utilisation.	The	challenge	of	regulating	access	to	information	is	well-known	from	intellectual	contributions,	where	IPR	are	assigned	to	inventors	to	warrant	compensation	for	their	non-tangible	input.	To	emphasise	this	connection,	Vogel	and	Ruiz	Muller	speak	of	homology	rather	than	analogy	between	natural	and	artificial	information	when	it	comes	to	their	benefits	and	value	(Ruiz	Muller,	2015).	Vogel	thus	suggests	protecting	providers	of	genetic	resources	with	rights	equivalent	to	IPR	(Vogel,	1994,	p:	38).16	While	the	discussion	of	property	rights	in	the	context	of	the	CBD	focuses	on	biodiversity,	the	earlier	analysis	of	human	genetic	resources	as	a	type	of	genetic	resources	suggests	that	in	this	context	too,	a	system	of	property	or	control	rights	over	natural	genetic	information	is	needed.	Because	of	the	absence	of	such	a	system	in	the	context	of	the	human	genome,	the	gap	of	providing	authority	over	genetic	information	to	exclude	others	has	been	filled	with	the	only	type	of	property	rights	over	information	that	has	been	established	so	far,	namely	with	IPR	in	the	form	of	gene	patents.	However,	there	are	good	arguments	against	IPR	as	a	scheme	to	attribute	rights	over	natural	genetic	sequences.	Patents	and	other	IPR	are	justified	as	rewards	for	inventions	that	are	characterised	as	useful,	novel	and	non-																																																								16	Sometimes,	Vogel	refers	to	“intellectual	property	rights	over	genetic	resources“	(Vogel,	1994:	pp	31,	37).	However,	in	the	context	of	his	book,	this	phrase	can	be	understood	as	rights	equivalent	to	IPR	(as	he	writes	on	p	38)	rather	than	direct	IPR	over	natural	genetic	information	such	as	gene	patents.		
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obvious,	which	are	criteria	that	cannot	be	attributed	to	natural	information.	This	tension	relates	to	the	paradox	mentioned	at	the	start	of	this	chapter	and	has	been	the	source	of	criticism	of	gene	patents	in	context	of	the	human	genome.	Critics	have	reasonably	argued	that	natural	genetic	sequences	should	count	as	discoveries	rather	than	patentable	inventions	(Gold,	2012;	Nuffild	Council	on	Bioethics,	2002;	Sagoff,	2004).17	Control	rights	over	natural	information	would	need	to	be	justified	based	on	other	criteria	than	IPR,	analogous	to	traditional	property	rights	over	material	natural	resources.		The	first	reason	why	IPR	are	so	important	in	the	context	of	genetic	resources	is	thus	pragmatic:	IPR	are	the	only	type	of	property	rights	over	information	that	have	been	established	to	date.	However,	since	IPR	have	been	designed	for	intellectual	information,	which	raises	very	different	claims	than	can	be	brought	forward	in	the	context	of	natural	genetic	resources,	it	seems	to	be	inappropriate	to	assign	IPR	for	natural	genetic	information	itself.		
5.2.	The	importance	of	intellectual	input		The	second	reason	for	the	important	role	of	IPR	in	the	discussion	on	genetic	resources	relates	to	the	previously	described	diversity	aspect	and	the	partially	potential	nature	of	the	value	of	genetic	resources	(see	section	4).	Together,	these	factors	result	in	the	need	for	a	large	investment	of	intellectual	input	to	produce	benefits.	As	biodiversity,	genetic	resources	are	characterised	by	a	wide	variety	of	different	organisms,	compounds	and	sequences	with	potential	value.	Identifying	and	using	the	actual	value	within	this	diversity	requires	an	independent	research	and	development	procedure	for	each	element	used.	It	can	be	countered	that	intellectual	input	also	plays	a	role	in	the	context	of	other	types	of	natural	resource	since,	for	instance,	the	development	of	motors	that	process	petrol	or	the	utilisation	of	rare	earths	in	mobile	phones	also	depended	on	human	inventions.	However,	it	is	argued	here	that	more	of	this	type	of	human	contribution	is	usually	necessary	in	the	case	of	genetic	resources	because	of	the	diversity	aspect	and	the	partially	potential	nature	of	their	value.	Profits	from	genetic	resources	as	natural	resources	are	thus	highly	dependent	on	intellectual	input.	This	tendency	is	reinforced	by	the	fact	that	the	utilisation	of	these	resources	is	by	no	means	obvious	but	highly	dependent	on	extensive	research	processes	and	inventive	steps.	This	is	in	contrast	to	biological	resources	such	as	fisheries	or	timber,	where	users	directly	consume	the	raw	material,	or	resources	such	as	diamonds	or	ores,	where	the	raw	material	is	of	high	cultural	value	and	its	processing	relatively	straightforward	and	obvious.		
5.3.	Resolving	the	paradox:	close	connection	between	natural	and	intellectual	contribution	At	the	beginning	of	this	chapter,	the	question	was	raised	as	to	whether	the	discussion	of	genetic	resources	as	a	type	of	natural	resource	and	at	the	same	time	a	subject	of	IPR	involves	a	paradox.	As	discussed,	the	case	of	gene	patents,	where	it	is	the	natural	contribution	(gene	sequence)	itself	that	has	been	patented,	may	indeed	be	paradoxical	in	this	sense	and	thus	highly	questionable.	However,	the	previous	chapter	shows	why	IPR	are	so	closely	interwoven	with	genetic	resources	even	when	no	gene	patents	are	involved.	According	to	this	line	of	argumentation,	IPR	should	not	be	understood	as	property	rights	over	genetic	resources	as	natural	information,	but	over	the	intellectual	input	required	to	make	use	of	this	natural	information.	It	is	thus	justifiable	that																																																									17	In	accordance	with	these	arguments,	the	United	States	Supreme	Court	decided	in	a	much-noticed	court	case	concerning	patents	of	Myriad	Genetics,	Inc.	on	the	BRCA1	and	BRCA2	genes	2013,	that	natural	gene	sequences	are	not	patentable	(e.g.,	Kesselheim	et	al.,	2013).		
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inventors	are	compensated	for	their	intellectual	contribution	to	the	product.	Nevertheless,	it	can	be	reasonably	argued	that	they	should	also	pay	for	the	natural	information	from	which	they	benefited	because	they	did	not	have	any	particular	claims	on	this	information,	which	they	received	and	used	for	free.	18	One	widely	discussed	option	to	acknowledge	this	natural	contribution	is	the	idea	of	requesting	disclosure	of	origin	in	IPR	applications,	which	would	trigger	the	duty	to	share	benefits	with	the	providers	of	this	natural	information	in	case	of	revenue	from	royalties	(e.g.,	Ruiz	Muller,	2015;	Sarnoff	&	Correa,	2006;	WIPO,	2004).	Several	countries	have	already	implemented	such	disclosure	requirments	in	their	IPR	legislation	(WIPO,	2017).	Henry	Vogel	and	Manuel	Ruiz	Muller	have	suggested	“bounded	openness”,	a	particular	model	taking	up	this	idea	(Ruiz	Muller,	2015	chapters	4,5).	This	model	suggests	that	natural	information	should	flow	freely	(openness)	until	revenue	is	made	from	intellectual	property	(boundedness),	in	which	case	the	requirement	to	disclose	the	use	of	genetic	resources	in	IPR	applications	would	trigger	the	duty	to	share	benefits.	Besides	this	particular	model	of	benefit	sharing,	the	bounded	openness	model	is	characterised	by	the	idea	of	a	multilateral	regime,	which	acknowledges	oligopoly	rights	of	all	states	with	incidences	of	the	genetic	resource	in	question	rather	than	monopoly	rights	of	singular	states.			 The	nexus	between	natural	and	human	contribution	is	particularly	close	in	the	case	of	crops	(key	example	1),	which	were	described	earlier	as	‘non-natural’	or	‘not	purely	natural’,	because	both	the	natural	and	human	contribution	have	formed	the	plant	species	in	its	current	state.	Again,	this	particular	situation	may	justify	a	special	type	of	regulation	such	as	what	is	already	in	place	with	plant	breeders’	rights.			
6.	Summary	and	conclusion	This	analysis	of	‘genetic	resources’	is	based	on	a	biological	interpretation	of	the	concept	and	an	enquiry	of	how	genetic	resources	are	being	used	and	where	their	value	occurs	in	practice.	The	resulting	understanding	of	genetic	resources	as	an	informational	type	of	natural	resource	points	out	that	the	CBD’s	definition	of	‘genetic	resources’,	which	refers	to	their	material,	is	not	consistent	with	how	genetic	resources	are	actually	being	used	and	valued.	However,	it	is	argued	here	that	the	NP’s	definition	of	utilisation	of	genetic	resources	as	working	with	the	“genetic	and/or	biochemical	composition	of	genetic	resources”	allows	consideration	of	the	informational	nature	of	this	type	of	resources	in	the	current	regulatory	framework.		The	article	aimed	to	develop	a	coherent,	consistent	and	comprehensive	analysis	of	this	concept	with	six	practical	examples	of	genetic	resource	utilisation	(three	classical	examples,	two	controversial	examples	and	a	biodiversity	example).	It	introduced	genetic	resources	as	a	particular	type	of	natural	resource	and	related	this	discussion	to	the	notion	of	genetic	resources	as	an	appreciation	of	biodiversity.	Moreover,	the	article	attempted	to	explain	the	important	role	of	IPR	in	the	discussion	of	genetic	resources	with	reference	to	their	informational	nature	as	well	as	the	diversity	and	potentiality	of	value	in	this	type	of	natural	resource,	which	is	expressed	in	the	connection	to	biodiversity.																																																										18	The	idea	that	there	should	be	compensation	for	the	use	of	natural	genetic	resources	does	not	depend	on	the	idea	of	national	sovereignty	over	genetic	resources,	according	to	which	it	is	the	states	in	which	the	respective	genetic	resources	can	be	found	that	should	be	compensated.	Instead,	cosmopolitans	for	whom	some	benefits	of	any	type	of	natural	resource	should	be	shared	globally,	or	environmentalists	who	state	that	some	of	the	profits	from	nature	should	go	back	into	the	protection	of	nature,	could	also	support	the	idea	of	compensation	for	the	use	of	natural	genetic	resources.			
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Furthermore,	it	has	been	shown	that	the	exclusion	of	human	genetic	resources	and	the	inclusion	of	biological	human	products	such	as	crops	in	the	regulation	of	genetic	resources	cannot	be	explained	solely	from	the	general	analysis	of	the	biological	function	of	genetic	resources	and	how	they	are	actually	being	used	and	valued.	The	reasons	to	exclude	human	genetic	resources	and	include	crops	in	the	regulatory	scheme	are	of	a	specific	nature,	meaning	that	human	genetic	resources	are	not	excluded	because	they	are	not	a	type	of	genetic	resources	but	because	they	raise	particular	issues	that	must	be	regulated	separately.	In	this	sense,	the	article	argues	that	in	the	case	of	other	controversial	uses	of	genetic	resources,	such	as	the	use	of	digital	sequences,	the	question	of	whether	or	not	they	should	be	included	in	the	regulatory	framework	also	cannot	be	reduced	to	the	question	of	whether	they	are	a	form	of	using	genetic	resources.	Instead,	specific	implications	of	putting	these	resources	under	an	ABS	scheme	must	also	be	considered.		One	of	the	main	objectives	of	this	article	is	bringing	the	discussion	of	the	concept	of	‘genetic	resources’	closer	to	the	conservation	biology	community.	The	current	discourse	focuses	on	the	legal	and	economic	implications	and	interpretation	of	this	concept.	However,	since	the	subject	is	a	biological	one	and	biodiversity	conservation	was	the	trigger	for	the	development	of	this	concept	in	the	first	place,	it	is	also	important	that	researchers	and	practitioners	in	the	field	of	conservation	biology	contribute	to	discussion	regarding	the	questions:	“What	are	genetic	resources?”	and	“How	should	they	be	regulated?”.	Conservation	biologists	can	provide	an	inside	view	on	what	it	means	to	utilise	genetic	resources.	In	return,	the	development	of	a	thorough	understanding	of	the	relation	between	biodiversity,	natural	resources	and	IPR	in	the	concept	of	‘genetic	resources’	is	important	for	designing	coherent	and	consistent	biodiversity	conservation	strategies.		
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